MedTrace Logo

Vitamin D for Polycystic Ovary Syndrome Clomiphene Resistant Women

NCT04010942 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-07-08

No results posted yet for this study

Summary

This study is determining the therapeutic effect of Vitamin D supplements to Pcos clomiphene resistant polycystic ovarian syndrome Women. Half of patients will receive Vitamin D with metformin while other half metformin only. Then both groups start clomiphene for 3 month

Conditions

  • PCOS
  • Vitamin D Deficiency

Interventions

DRUG

Vit D

Injection

DRUG

Metformin

tablets

DRUG

Clomiphene

Tablet

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Reda MK Ghanem, Lecturer · Obstetrics & Gynecology department Faculty of medicine, Ain shams University.

  • Ahmed MN Hashaad, Professor · Obstetrics & Gynecology department - Faculty of medicine, Ain shams University.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-12-30
Completion
2019-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010942 on ClinicalTrials.gov